JP2001226293A - Taking assisting agent - Google Patents

Taking assisting agent

Info

Publication number
JP2001226293A
JP2001226293A JP2000039421A JP2000039421A JP2001226293A JP 2001226293 A JP2001226293 A JP 2001226293A JP 2000039421 A JP2000039421 A JP 2000039421A JP 2000039421 A JP2000039421 A JP 2000039421A JP 2001226293 A JP2001226293 A JP 2001226293A
Authority
JP
Japan
Prior art keywords
lecithin
dosage
aid
present
ascorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000039421A
Other languages
Japanese (ja)
Inventor
Kazuko Sue
和子 須恵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOTARO KANPO SEIYAKU KK
Original Assignee
KOTARO KANPO SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOTARO KANPO SEIYAKU KK filed Critical KOTARO KANPO SEIYAKU KK
Priority to JP2000039421A priority Critical patent/JP2001226293A/en
Publication of JP2001226293A publication Critical patent/JP2001226293A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a taking assisting agent useful as an additive for facilitating the taking of a drug or health food, etc., which are extremely difficult to take owing to the characteristic taste and smell. SOLUTION: The objective taking assisting agent contains a combination of lecithin and milk flavor, a gelling agent, ascorbic acid and trisodium citrate at an (ascorbic acid:trisodium citrate) ratio of (3-5):1. The above agent may further contain cacao powder and chocolate flavor to obtain an agent for a bitter drug or further contain an orange flavor for an acidulant drug.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、医薬品や健康食品
等に特異な味、臭いがあり非常に服用しにくい薬剤また
は食品などに添加することにより服用し易くする服用補
助剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a dosage aid which is easy to take by adding it to a drug or food which has a peculiar taste and smell in pharmaceuticals and health foods and which is very difficult to take.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】古来よ
り良薬は口に苦しと言われるように、医薬品や健康食品
の原料、製品は、本来特異な味や臭いを持っているもの
が多く、これを飲みやすくまたは食べやすくするため
に、錠剤や散剤または顆粒剤等に製剤化されている。し
かし、これらの固形剤は嚥下力が弱い高齢者や乳幼児で
は、服用が困難で食道にひっかかって炎症を起こさせる
こともある。また散剤や顆粒剤は、高齢者では、入れ歯
と歯ぐきの間に入ったりして服用しにくいし、乳幼児で
は舌や喉に付着し服用しにくい。そこで水(白湯)に溶か
して服用させようとした場合に、特異な味、臭いが強ま
って服用できないといった問題点が指摘されている。
2. Description of the Related Art As good medicines have been said to have a painful mouth since ancient times, many raw materials and products of pharmaceuticals and health foods have inherently unique tastes and odors. In order to make it easy to drink or eat, it is formulated into tablets, powders or granules. However, these solid preparations are difficult to take for elderly people and infants who have a weak swallowing ability, and they may catch on the esophagus and cause irritation. Also, powders and granules are difficult to take for elderly people because they fall between dentures and gums, and for infants, they adhere to the tongue and throat and are difficult to take. Therefore, it has been pointed out that, when it is intended to dissolve in water (white water) and take it, it cannot be taken due to an increase in unique taste and smell.

【0003】これらの問題を解決するために種々の工夫
が行われてきた。その代表例が苦味低減方法(特許番号
第2508555号)や、医薬品等をゼリー状に加工
して服用する方法である。しかし苦味が強い物質や特異
な味、臭いの強い物質では服用時の違和感を無くすこと
はできず、より服用し易くする補助剤が求められてい
た。
[0003] Various devices have been devised to solve these problems. Representative examples are a method of reducing bitterness (Patent No. 2508555) and a method of processing a medicine or the like into a jelly and taking it. However, a substance having a strong bitterness, a peculiar taste, or a substance having a strong odor cannot eliminate the discomfort at the time of taking the drug, and there has been a demand for an adjuvant to make the drug easier to take.

【0004】[0004]

【課題を解決するための手段】本発明者らは種々の研究
を行った結果、レシチンをマスキング剤として用い、レ
シチンの安定化剤として、pHの調整剤、酸味剤でもあ
るアスコルビン酸およびこれに対して一定割合のクエン
酸三ナトリウムを添加することによって、ゲル化剤を含
む優れた服用補助剤が得られることが判明した。
The present inventors have conducted various studies and found that as a result of using lecithin as a masking agent, as a stabilizer for lecithin, a pH adjuster, ascorbic acid which is also an acidulant, and On the other hand, it has been found that by adding a certain percentage of trisodium citrate, an excellent dosage aid containing a gelling agent can be obtained.

【0005】レシチンは化学的にはグリセリンに結合し
た2分子の長鎖脂肪酸を親油基とし、別に結合するリン
酸およびこれに結合するコリンを親水基とするリン脂質
でこれらを総称してレシチンという。本発明はレシチン
がミルク様の味および舌ざわりがするので、ミルク香味
料を加えてよりミルク香味を強める一方、レシチンの安
定化剤であり、かつpHの調整剤および酸味剤でもある
アスコルビン酸、およびアスコルビン酸3〜5部に対し
てクエン酸三ナトリウムを1部の割合で加えることによ
り、ゲル化剤を含む服用補助剤としての効果が著しく改
善されるとの知見を得て完成された。
[0005] Lecithin is a phospholipid chemically comprising two molecules of long-chain fatty acids chemically bonded to glycerin as a lipophilic group, and phosphate as a separate bond and choline as a hydrophilic group as a bond thereto. These are collectively referred to as lecithin. That. The present invention relates to ascorbic acid, which is a lecithin stabilizer and a pH adjuster and a sour agent, while adding a milk flavor to enhance the milk flavor because lecithin has a milky taste and texture. It has been found that the addition of trisodium citrate in an amount of 1 part to 3 to 5 parts of ascorbic acid significantly improves the effect as a dosage aid containing a gelling agent.

【0006】本発明はレシチンとミルク香味料の組合
せ、ゲル化剤、およびアスコルビン酸およびクエン酸三
ナトリウムを含み、アスコルビン酸:クエン酸三ナトリ
ウム=3〜5:1の割合で含まれることを特徴とする服
用補助剤を提供するものである。
The present invention comprises a combination of a lecithin and a milk flavor, a gelling agent, and ascorbic acid and trisodium citrate, wherein the ascorbic acid: trisodium citrate is contained in a ratio of 3 to 5: 1. And a dosage aid.

【0007】[0007]

【発明の実施の態様】本発明の服用補助剤が対象とする
製品は、医薬品あるいは健康食品で、健康維持のために
は是非とも必要な製品でありながら、特異な味、臭いの
ために服用しにくい製品、水に溶かした際に特異な味、
臭いを呈するに至った製品、無味無臭であるが口中に含
んだ際に特異な違和感を呈する製品などである。
BEST MODE FOR CARRYING OUT THE INVENTION The products targeted by the dosage aid of the present invention are pharmaceuticals or health foods, which are indispensable products for maintaining health, but which are taken due to their unique taste and smell. Products that are difficult to make, unique taste when dissolved in water,
Products that have come to have an odor, and products that are tasteless and odorless but have a peculiar unpleasant sensation when contained in the mouth.

【0008】本発明の服用補助剤は、柴胡清肝湯、柴苓
湯、小青竜湯、香蘇散、かっ香正気散、柴胡桂枝湯、柴
胡桂枝乾姜湯、黄連解毒湯、麻黄湯、人参湯、麻杏甘石
湯、苓甘姜味辛夏仁湯、参蘇飲、荊芥連翹湯、三黄瀉心
湯、葛根湯、葛根湯加辛夷川きゅう、安中散、小柴胡
湯、当帰四逆加呉茱萸生姜湯、呉茱萸湯、九味檳ろう
湯、大柴胡湯、辛夷清肺湯、大建中湯などの漢方薬およ
びある種の抗生物質に用いることができる。
[0008] The dosage aids of the present invention include Saiko Seikoto, Sairei-to, Shoseiryuto, Koso-san, Kakko Seiki-san, Saiko-keishi-to, Saiko-keishi-kenkyo-to, Oren-dokuto-to, Maoto-to , Ginseng hot water, makyokanseki hot water, ryo ginger ginseng hot summer hot water, sanso drink, jingaku liyoto, sankoshashinto, kakkonto, kakkonto kashiikawa kyu, annakasan, shosaikoto, tokishishi It can be used for Chinese herbal medicines such as Sakaka Goshuyu Ginger-To, Goshuyu-To, Kumi-Benrou-To, Dai-Saiko-To, Shin-Sei-Hai-To, Daikenchu-To, and certain antibiotics.

【0009】この明細書にいう「苦味薬のために」と
は、苦味やえぐみの強い医薬品、健康食品等のための服
用補助剤をいい、漢方薬としては、例えば柴胡清肝湯、
柴苓湯、およびある種の抗生物質(例えば、マクロライ
ド系、セフェム系)、また「酸味薬のために」とは、酸
味および香りの強い医薬品、健康食品等のための服用補
助剤をいい、漢方薬としては、小青竜湯、香蘇散、かっ
香正気散などを挙げることができる。
[0009] The term "for bitter medicines" as used in this specification refers to medications with strong bitterness and astringency, supplements for health foods, and the like.
Sairei-to and certain antibiotics (e.g., macrolides, cephems), and `` for sour drugs '' refer to medications with strong acidity and aroma, and supplements for health foods, etc. Examples of Chinese herbal medicines include Shoseiryu-to, Koso-san, and Kakko-Maseki-san.

【0010】レシチンはそれ自体は若干油っぽい味が
し、臭いはほとんどないが舌ざわりがミルク様であり、
数グラムを一度に服用しようとすると服用しづらい。そ
こでレシチンにミルク香味料を添加し、レシチンをより
ミルクに類似したものにし服用を容易にする。
[0010] Lecithin itself has a slightly oily taste, has little smell, but has a milky tongue texture,
It is difficult to take several grams at once. Thus, a milk flavor is added to lecithin to make the lecithin more similar to milk and easier to take.

【0011】レシチンは市販品を用いることができる。
レシチンは本発明の服用補助剤中に4〜50重量%、好
ましくは6〜40重量%、より好ましくは、7〜30重
量%含まれる。
Commercially available lecithin can be used.
Lecithin is contained in the dosage aid of the present invention in an amount of 4 to 50% by weight, preferably 6 to 40% by weight, more preferably 7 to 30% by weight.

【0012】アスコルビン酸はレシチンの安定化剤であ
り、pHの調整剤および酸味剤でもある。さらに味を良
くするために、矯味剤としてクエン酸三ナトリウムを、
アスコルビン酸3〜5に対してクエン酸三ナトリウム1
を加える。より好ましくはアスコルビン酸4に対してク
エン酸三ナトリウム1を加える。アスコルビン酸および
クエン酸三ナトリウムは食品添加物として市販されてい
るものを使用することができる。
Ascorbic acid is a stabilizer of lecithin, a regulator of pH and a sour agent. To further improve the taste, trisodium citrate as a flavoring agent,
Trisodium citrate 1 for ascorbic acid 3-5
Add. More preferably, trisodium citrate 1 is added to ascorbic acid 4. Ascorbic acid and trisodium citrate available on the market as food additives can be used.

【0013】アスコルビン酸は本発明の服用補助剤中、
0.2〜3.0重量%、好ましくは0.6〜2.0重量%、
より好ましくは、1.0〜1.5重量%含まれる。
[0013] Ascorbic acid is included in the dosage aid of the present invention,
0.2-3.0% by weight, preferably 0.6-2.0% by weight,
More preferably, the content is 1.0 to 1.5% by weight.

【0014】本発明の服用補助剤はゲル化剤を含んでお
り、水または湯に溶解するとゾル状になり、これを冷却
するとゼリー状になる。
The dosage aid of the present invention contains a gelling agent, and becomes a sol when dissolved in water or hot water, and becomes a jelly when cooled.

【0015】本発明で用い得るゲル化剤としては、例え
ば、市販されている多糖類である種子由来のローカスト
ビーンガム、グアーガムなど、海藻由来のκ−カラギー
ナン、寒天、アルギン酸ナトリウムなど、タンパク質由
来のゼラチン、カゼインなど、微生物由来のキサンタン
ガム、ジェランガム、カードラン、プルランなど、根茎
由来のグルコマンナン、果実由来のペクチンなどを挙げ
ることができる。これらのゲル化剤には市販のものを用
いればよい。
Examples of the gelling agent that can be used in the present invention include, for example, commercially available polysaccharides such as seed-derived locust bean gum and guar gum, seaweed-derived κ-carrageenan, agar, and sodium alginate. Gelatin, casein, etc., microorganism-derived xanthan gum, gellan gum, curdlan, pullulan, etc., rhizome-derived glucomannan, fruit-derived pectin, etc. can be mentioned. Commercially available products may be used as these gelling agents.

【0016】好ましくは、ローカストビーンガム、κ−
カラギーナン、キサンタンガム、寒天、ゼラチン、グル
コマンナン、ペクチンであり、より好ましくは、ローカ
ストビーンガム、κ−カラギーナン、キサンタンガムで
ある。
Preferably, locust bean gum, κ-
Carrageenan, xanthan gum, agar, gelatin, glucomannan, and pectin; and more preferably locust bean gum, kappa-carrageenan, and xanthan gum.

【0017】上記のゲル化剤を1種または通常は2種以
上組合せて用いる。ゲル化剤は本発明の服用補助剤中、
4〜20重量%、好ましくは7〜17重量%、より好ま
しくは、9〜15重量%含まれる。
The above-mentioned gelling agents are used singly or in combination of two or more. The gelling agent in the dosage aid of the present invention,
It is contained in an amount of 4 to 20% by weight, preferably 7 to 17% by weight, and more preferably 9 to 15% by weight.

【0018】本発明の服用補助剤は具体的には、例えば
レシチン(7〜30重量%)とκ−カラギーナン(7〜
11重量%)、ローカストビーンガム(2〜4重量
%)、ミルク香料(1〜3重量%)を含有する混合末
に、甘味料(45〜79重量%)を加えて混合したものを
基本的なベースとするか、または上記のκ−カラギーナ
ンおよびローカストビーンガムからなるゲル化剤に代え
て、κ−カラギーナン16%、ローカストビーンガム1
4%およびキサンタンガム11%のゲル化剤およびその
他59%を含むゲル化製剤を含むもの(FG2432、
新田ゼラチン社製)(6重量%〜10重量%)を基本的な
ベースとする。
The dosage aid of the present invention is, for example, lecithin (7 to 30% by weight) and κ-carrageenan (7 to
11% by weight), a mixture containing locust bean gum (2-4% by weight), and a milk flavor (1-3% by weight), and a sweetener (45-79% by weight) mixed. Or a gelling agent comprising κ-carrageenan and locust bean gum as described above, κ-carrageenan 16%, locust bean gum 1
Including a gelling formulation containing 4% and 11% xanthan gum as a gelling agent and 59% other (FG2432,
Nitta Gelatin) (6% by weight to 10% by weight) is used as a basic base.

【0019】甘味料はアスパルテーム、アマルティ、砂
糖及び液糖、キシリトール系甘味料等から選ばれる。こ
れらの甘味料は、食品用として市販されているものが使
用できる。
The sweetener is selected from aspartame, amalti, sugar and liquid sugar, xylitol-based sweeteners and the like. As these sweeteners, those commercially available for foods can be used.

【0020】甘味料は本発明の服用補助剤中、36〜9
0重量%、好ましくは50〜85重量%、より好ましく
は、45〜79重量%含まれる。
The sweetener is contained in the dosage aid of the present invention in an amount of 36 to 9%.
0% by weight, preferably 50 to 85% by weight, more preferably 45 to 79% by weight.

【0021】さらに、本発明によれば、特に苦味の強い
医薬品や健康食品等については、上記の基本的なベース
にカカオ末およびチョコレート香味料をさらに添加する
ことによって、服用補助剤としてより優れたものを得る
ことができる。カカオ末の添加量は本発明の服用補助剤
中、4〜18重量%、好ましくは8〜16重量%、より
好ましくは、12〜15重量%含まれる。
Furthermore, according to the present invention, particularly for pharmaceuticals and health foods having a particularly strong bitter taste, cocoa powder and chocolate flavor are further added to the above-mentioned basic base, so that they are more excellent as a dosage aid. You can get things. The amount of cocoa powder added is 4 to 18% by weight, preferably 8 to 16% by weight, more preferably 12 to 15% by weight in the dosage aid of the present invention.

【0022】チョコレート香料は市販のものを用いるこ
とができ、チョコレート風味をつけるために適当量添加
する。
As the chocolate flavor, a commercially available one can be used, and an appropriate amount is added to impart a chocolate flavor.

【0023】本発明による苦味薬のための服用補助剤
は、レシチン100〜1640部、アマルティ1770
〜3500部、アスパルテーム30〜60部、アスコル
ビン酸10〜90部、クエン酸三ナトリウム5〜30
部、カラギーナンSWG・JおよびカラギーナンWG−
108からなるカラギーナン 75〜540部とローカス
トビーンガム45〜150部からなるゲル化剤、カカオ
末200〜850部、チコレート香味料30〜100部
の割合で配合される。または上記のゲル化剤に代えて、
κ−カラギーナン16%、ローカストビーンガム14%
およびキサンタンガム11%のゲル化剤およびその他5
9%を含むゲル化製剤20〜70部を配合することがで
きる。
The dosage aid for bitter medicines according to the present invention comprises 100 to 1640 parts of lecithin, Amalti 1770
~ 3500 parts, aspartame 30 ~ 60 parts, ascorbic acid 10 ~ 90 parts, trisodium citrate 5 ~ 30
Department, Carrageenan SWG ・ J and Carrageenan WG-
A gelling agent consisting of 75 to 540 parts of carrageenan consisting of 108 and 45 to 150 parts of locust bean gum, 200 to 850 parts of cocoa powder, and 30 to 100 parts of chicolate flavor are blended. Or, instead of the above gelling agent,
κ-carrageenan 16%, locust bean gum 14%
And 11% gelling agent of xanthan gum and other 5
20 to 70 parts of a gelled preparation containing 9% can be blended.

【0024】特に、酸味の強い医薬品や健康食品につい
ては、上記の基本的なベースにオレンジ香料を添加す
る。オレンジ香味料は市販のものを用いることができ、
オレンジ風味をつけるために適当量添加する。
In particular, for medicines and health foods having a strong acidity, an orange flavor is added to the above-mentioned basic base. Commercially available orange flavors can be used,
Add the appropriate amount to add orange flavor.

【0025】本発明による酸味薬のための服用補助剤
は、レシチン100〜1640部、アマルティ1770
〜3500部、アスパルテーム30〜60部、アスコル
ビン酸10〜90部、クエン酸三ナトリウム5〜30
部、カラギーナンSWG・JおよびカラギーナンWG−
108からなるカラギーナン 75〜540部およびロー
カストビーンガム45〜150部からなるゲル化剤、オ
レンジ香味料30〜100部の割合で配合される。また
は上記のゲル化剤に代えて、κ−カラギーナン16%、
ローカストビーンガム14%およびキサンタンガム11
%のゲル化剤およびその他59%を含むゲル化製剤20
〜70部を配合することができる。
The dosage aid for sour agents according to the invention comprises 100 to 1640 parts of lecithin, Amalti 1770
~ 3500 parts, aspartame 30 ~ 60 parts, ascorbic acid 10 ~ 90 parts, trisodium citrate 5 ~ 30
Department, Carrageenan SWG ・ J and Carrageenan WG-
A gelling agent consisting of 75 to 540 parts of carrageenan consisting of 108 and 45 to 150 parts of locust bean gum, and 30 to 100 parts of an orange flavor are blended. Or, instead of the above gelling agent, κ-carrageenan 16%,
Locust bean gum 14% and xanthan gum 11
Formulation 20% gelling agent and 59% other
Up to 70 parts can be blended.

【0026】本発明の服用補助剤には、安定剤、保存
剤、着色剤などおよび製品として最終的な味を調整する
ためにさらに少量の調味料および香料を添加することが
できる。
[0026] The dosage aid of the present invention may contain stabilizers, preservatives, coloring agents and the like and a small amount of a seasoning and a flavor in order to adjust the final taste as a product.

【0027】上記に挙げた混合粉末はそのまま粉末剤と
して用いることもできるが、取り扱いの簡便性を考慮し
て、通常の顆粒剤の調製法により顆粒剤として用いるの
が好ましい。
Although the above-mentioned mixed powder can be used as a powder as it is, it is preferable to use it as a granule by a usual method for preparing granules in consideration of easy handling.

【0028】本発明の服用補助剤は1回の使用量が2〜
8g、好ましくは4〜6gである。一例を挙げれば、1
回の服用量の薬剤および本発明の服用補助剤5gに、水
もしくは白湯を加えてゾル状としてそのまま服用する
か、80℃の熱水を加えて攪拌溶解後冷蔵庫で冷却しゼ
リー状として服用する。
The dose of the dosage aid of the present invention is 2 to 2 at a time.
8 g, preferably 4 to 6 g. For example, 1
Water or plain hot water is added to 5 g of the medicine and the dosage aid of the present invention as a sol, and the mixture is taken as it is, or hot water at 80 ° C. is added, stirred and dissolved, cooled in a refrigerator, and taken as a jelly. .

【0029】[0029]

【実施例】以下に本発明の服用補助剤の実施例を具体的
に説明する。本発明はこれらに限定されるものではな
い。
EXAMPLES Examples of the dosage aid of the present invention will be specifically described below. The present invention is not limited to these.

【0030】実施例1 チョコレート・ミルク味顆粒服用補助剤(湿式造粒) レシチン(ベネコートBMI−40、花王(株)、食品添
加物用レシチン製剤)を410g、κ−カラギーナンと
してGENU GEL−SWG−J(ハーキュリーズ・
ジャパン(株))を296gおよびGENU GEL−WG
−108を178g、ローカストビーンガムとしてGE
NUGUM−RL−200−J(ハーキュリーズ・ジャ
パン(株))を142g、チョコレート香料としてチョコ
レートコートンD06209(小川香料(株))を95g、
ミルク香料としてミルクコートンD06214(小川香
料(株))が95g、ココア末(カカオ末100%)を71
0g、アスコルビン酸を64g、クエン酸三ナトリウム
を16g、アスパルテームを46g、アマルティを29
48g、をそれぞれ量りとり混合し、エタノール(95
%)2000mlを加えて練合した。練合物を12号ふ
るいで押し出し顆粒を得た後、乾燥しチョコレート・ミ
ルク味湿式造粒顆粒を得た。1回の使用量は2〜8g、
好ましくは4〜6gである。
Example 1 Aid for Chocolate and Milk Taste Granules (Wet Granulation) 410 g of lecithin (Benecoat BMI-40, Kao Corporation, lecithin preparation for food additive), GENU GEL-SWG- as kappa-carrageenan J (Hercules
296 g and GENU GEL-WG
178 g of -108, GE as locust bean gum
142 g of NUGUM-RL-200-J (Hercules Japan KK), 95 g of chocolate courton D06209 (Ogawa fragrance) as chocolate flavor,
95 g of milk courton D06214 (Ogawa Koran Co., Ltd.) and 71 of cocoa powder (100% of cocoa powder) as a milk flavor.
0 g, ascorbic acid 64 g, trisodium citrate 16 g, aspartame 46 g, Amalti 29
48 g, respectively, were weighed and mixed, and ethanol (95
%) And kneaded. The kneaded product was extruded with a No. 12 sieve to obtain granules, which were then dried to obtain chocolate / milk flavor wet granules. Each use is 2-8g,
Preferably it is 4-6 g.

【0031】実施例2 実施例1において、レシチンとして、410gのベネコ
ートBMI−40に代えて、セントロレックスF(米国
セントラルソーヤ社製、食品添加物用レシチン製剤)1
400gを用いる以外は実施例1と同様に行った。
Example 2 In Example 1, Centrolex F (a lecithin preparation for food additives, manufactured by Central Sawyer USA) was used in place of 410 g of Benecoat BMI-40 in Example 1 as lecithin.
The procedure was performed in the same manner as in Example 1 except that 400 g was used.

【0032】実施例3および4 実施例1および2において、κ−カラギーナンとしてG
ENU GEL−SWG−J(ハーキュリーズ・ジャパ
ン(株))296gおよびGENU GEL−WG−108
の178gおよびローカストビーンガムとしてGENU
GUM−RL−200−J(ハーキュリーズ・ジャパン
(株))142gからなるゲル化剤に代えて、FG243
2(新田ゼラチン社製)500gを用いる以外は実施例1
および2と同様に行った。
Examples 3 and 4 In Examples 1 and 2, G was used as κ-carrageenan.
296 g of ENU GEL-SWG-J (Hercules Japan KK) and GENU GEL-WG-108
178g and GENU as locust bean gum
GUM-RL-200-J (Hercules Japan
FG243 instead of 142 g of gelling agent
Example 1 except that 500 g of Nitta Gelatin 2 was used.
And 2.

【0033】実施例5 オレンジ・ミルク味顆粒服用補助剤(湿式造粒) レシチン(ベネコートBMI−40)を374g、κ−
カラギーナンとしてGENU GEL−SWG−Jを1
90g、GENU GEL−WG−108を115g、
ローカストビーンガムとしてGENUGUM−RL−2
00−Jを135g、オレンジ香料としてオレンジコー
トンD07439(小川香料(株))を88g、ミルク香料
としてミルクコートンD06214を88g、アスコル
ビン酸を56g、クエン酸三ナトリウムを14g、アス
パルテームを60g、アマルティを3380gをそれぞ
れ量りとり混合し、エタノール(95%)2000ml
を加えて練合したものを12号ふるいで押し出し顆粒を
得た後、乾燥しオレンジ・ミルク味湿式造粒顆粒を得
た。1回使用量は2〜8g、好ましくは4〜6gであ
る。
Example 5 Orange Milk Flavor Granule Supplement (Wet Granulation) 374 g of lecithin (Benecoat BMI-40), κ-
1 GENU GEL-SWG-J as carrageenan
90 g, 115 g of GENU GEL-WG-108,
GENUGUM-RL-2 as locust bean gum
135 g of 00-J, 88 g of Orange Courton D07439 (Ogawa Perfume Co., Ltd.) as an orange flavor, 88 g of Milk Courton D06214 as a milk flavor, 56 g of ascorbic acid, 14 g of trisodium citrate, 60 g of aspartame, Amalti And weigh 3380 g of each, and then mix, and 2,000 ml of ethanol (95%)
The resulting mixture was extruded through a No. 12 sieve to obtain extruded granules, which were then dried to obtain orange-milk flavored wet granulated granules. The amount used at one time is 2 to 8 g, preferably 4 to 6 g.

【0034】実施例6 実施例5において、レシチンとして、374gのベネコ
ートBMI−40に代えて、セントロレックスF(米国
セントラルソーヤ社製、食品添加物用レシチン製剤)1
200gを用いる以外は実施例5と同様に行った。
Example 6 In Example 5, Centrolex F (a lecithin preparation for food additives, manufactured by Central Sawyer USA) was used in place of 374 g of Benecoat BMI-40 in Example 5 as lecithin.
The procedure was performed in the same manner as in Example 5 except that 200 g was used.

【0035】実施例7および8 実施例5および6において、κ−カラギーナンとしてG
ENU GEL−SWG−Jを190g、GENU G
EL−WG−108を115g、ローカストビーンガム
としてGENUGUM−RL−200−Jを135gか
らなるゲル化剤に代えて、FG2432(新田ゼラチン
社製)500gを用いる以外は実施例5および6と同様
に行った。
Examples 7 and 8 In Examples 5 and 6, G was used as κ-carrageenan.
190 g of ENU GEL-SWG-J, GENU G
Same as Examples 5 and 6 except that instead of using a gelling agent consisting of 115 g of EL-WG-108 and 135 g of GENUGUM-RL-200-J as locust bean gum, 500 g of FG2432 (manufactured by Nitta Gelatin Co.) is used. I went to.

【0036】実施例9〜12 チョコレート・ミルク味顆粒服用補助剤(乾式造粒) 実施例1〜4に示したレシチン以下アマルティまでをそ
れぞれ量りとり混合し、圧縮成型機で圧縮成形後、粉砕
機で粉砕し、12号ふるいを通してチョコレート・ミル
ク味乾式造粒顆粒を得た。
Examples 9-12 Adjuvants for taking chocolate and milk flavor granules (dry granulation) Each of lecithin and amalti shown in Examples 1-4 was weighed, mixed and compression-molded by a compression molding machine. And passed through a No. 12 sieve to obtain dry milk-granulated chocolate-milk flavored granules.

【0037】実施例13〜16 オレンジ・ミルク味顆粒服用補助剤(乾式造粒) 実施例5〜8に示したレシチン以下アマルティまでを其
々量りとり混合し、圧縮成型機で圧縮成形後、粉砕機で
粉砕し、12号ふるいを通してオレンジ・ミルク味乾式
造粒顆粒を得た。
Examples 13-16 Adjuvants for taking orange / milk taste granules (dry granulation) The lecithin and amalti shown in Examples 5-8 were individually weighed, mixed, compression-molded with a compression molding machine, and then crushed. The resulting mixture was pulverized by a mill and passed through a No. 12 sieve to obtain dry milk-granulated flavor granules.

【0038】官能試験 官能試験は本発明の服用補助剤(I)、比較試験の対象と
して、苦味低減方法(特許番号 第2508555号)
に記載の服用補助剤(II)、ならびに文献報告例(文献
名:漢方製剤における剤型の検討−第5報−;薬局、第
44巻(第7号)971−977頁、1993年)記載の
服用補助剤(III)を用い、対照(C)には被検薬剤を水あ
るいは湯で溶かして用いた。なお、官能試験のパネルは
8名(男性6名、女性2名)であり、評価は++(非常
に服用し易い)、+(服用し易い)、±(変わらな
い)、−(服用しにくい)、−−(非常に服用しにく
い)で表わした。
Sensory test The sensory test is a dosage aid (I) of the present invention, and a bitterness reducing method (patent No. 2508555) as a target of a comparative test.
And the literature reports (Literature: Examination of dosage forms in Kampo preparations-Report 5; Pharmacy, 44 (7) 971-977, 1993) And the control drug (C) was prepared by dissolving the test drug in water or hot water. The panel of the sensory test was 8 panelists (6 males and 2 females), and the evaluation was ++ (very easy to take), + (easy to take), ± (unchanged),-(hard to take) ), --- (very difficult to take).

【0039】官能試験1 小児を対象としているが非常に苦味の強い漢方薬である
柴胡清肝湯エキス細粒(小太郎漢方製薬(株))3gに実
施例1〜4の服用補助剤顆粒5gを加え、80℃の熱水
50mlを加え良く撹拌した後、冷蔵庫で冷却しゼリー
化した。コントロール(C)は、柴胡清肝湯エキス細粒3
gに80℃の熱水50mlを加えよく攪拌溶解後、冷却
した。
Sensory Test 1 To 3 g of Saiko Seikoto extract fine granules (Kotaro Kampo Pharmaceutical Co., Ltd.), which is a Chinese medicine intended for children but having a very strong bitter taste, was added 5 g of the adjuvant granules of Examples 1-4. After adding 50 ml of 80 ° C. hot water and stirring well, the mixture was cooled in a refrigerator to form a jelly. Control (C) is Saiko Seikoto extract fine granules 3
50 g of hot water at 80 ° C. was added to the g, and the mixture was stirred well and dissolved, and then cooled.

【0040】苦味低減方法に記載の服用補助剤(II)につ
いては、特許第2508555号の記載に基づいて、チ
ョコレート味付剤(下記参照)10.44gおよびκ−カ
ラギーナン0.76gに、柴胡清肝湯エキス細粒3.0g
を加え、これに80℃の熱水50mlを加えて攪拌溶解
した後、冷却しゼリー化した。 チョコレート味付剤 グラニュー糖 186.6g パウダーチョコレート8004(香料) 3.0g SRチョコレート色素 No.2(色素) 3.0g ネッスルココアPMT 16.0g 合計 208.6g/40個
With respect to the dosage aid (II) described in the method for reducing bitterness, 10.44 g of chocolate flavoring agent (see below) and 0.76 g of κ-carrageenan were added to Saiko Kiyoliver based on the description of Japanese Patent No. 2508555. Hot water extract fine granules 3.0g
Was added thereto, and 50 ml of hot water at 80 ° C. was added to dissolve with stirring. Chocolate flavoring granulated sugar 186.6 g Powder chocolate 8004 (flavor) 3.0 g SR chocolate pigment No. 2 (pigment) 3.0 g Nestle Cocoa PMT 16.0 g Total 208.6 g / 40

【0041】文献報告例記載の服用補助剤(III)につい
ては、文献の記載に基づいて、柴胡清肝湯エキス細粒
3.0gに単シロップ8mlと熱水3mlを加え、加温
しながら溶解する。製菓用ゼライス0.55gを2ml
の水に膨潤させ湯煎で溶解した。上記にミルクココア粉
末(森永製菓(株))2.5gと湯3mlを加えて加温しな
がら溶解し、冷却してゼリー化する。
With respect to the dosage aid (III) described in the literature report example, 8 ml of a simple syrup and 3 ml of hot water were added to 3.0 g of fine granules of Saiko Seikoto extract based on the description of the literature and dissolved while heating. . 2 ml of 0.55 g of confectionery jelly
Swelled in water and dissolved in hot water. 2.5 g of milk cocoa powder (Morinaga Seika Co., Ltd.) and 3 ml of hot water are added to the above, dissolved while heating, and cooled to jelly.

【0042】比較官能試験を実施した結果を表1に示
す。 表1 C:対照(柴胡清肝湯エキス細粒3gを熱水50mlに溶
解) I−1:本発明の実施例1の服用補助剤 I−2:本発明の実施例2の服用補助剤 I−3:本発明の実施例3の服用補助剤 I−4:本発明の実施例4の服用補助剤 II:苦味低減方法に記載の服用補助剤 III:文献報告例記載の服用補助剤
Table 1 shows the results of the comparative sensory test. Table 1 C: Control (3 g of Saiko Seikoto extract fine particles are dissolved in 50 ml of hot water) I-1: Auxiliary agent for Example 1 of the present invention I-2: Auxiliary agent for Example 2 of the present invention I- 3: Taking aid of Example 3 of the present invention I-4: Taking aid of Example 4 of the present invention II: Taking aid described in the method of reducing bitterness III: Taking aid described in literature report examples

【0043】本発明の服用補助剤は対照および比較のた
めの文献報告例の服用補助剤に比較して明らかに優れた
結果が得られた。服用補助剤としてチョコレート・ミル
ク味についてレシチンの種類およびゲル化剤の種類に関
係なく良好な効果が得られることも判明した。
The dosage aid of the present invention showed clearly superior results as compared with the dosage aid of the reference and the literature reported for comparison. It has also been found that good effects can be obtained on the taste of chocolate and milk regardless of the type of lecithin and the type of gelling agent as a dosage aid.

【0044】官能試験2 えぐみを伴う酸味を持ち、加えて特有の臭いを持つ漢方
薬である小青竜湯煎液(マオウ3g、シャクヤク3g、
カンキョウ3g、カンゾウ3g、ケイヒ3g、サイシン
3g、ゴミシ3g及びハンゲ6gを其々量りとり混合
し、水540mlを加え、弱火で2時間、煎出し、茶こ
しにガーゼを重ねてろ過した後50℃程度まで冷却して
得た煎液)45mlに実施例5〜8の顆粒4.5gを加
え良く撹拌した後、冷却しゾル状の溶液とした(本発明
の服用補助剤:I)。
Sensory test 2 Shoseiryu-tosen (3 g of ephedra, 3 g of peony), a Chinese herb having a sourness accompanied by astringency and a peculiar smell
3 g of liquorice, 3 g of liquorice, 3 g of cinnamon, 3 g of cycin, 3 g of garnish, and 6 g of hange were weighed and mixed, 540 ml of water was added, brewed over a low heat for 2 hours, filtered over gauze on a tea strainer, and then filtered to about 50 ° C. 4.5 g of the granules of Examples 5 to 8 were added to 45 ml of the decoction obtained by cooling to room temperature, and the mixture was stirred well, followed by cooling to obtain a sol-like solution (dose aid of the present invention: I).

【0045】対照(C)は小青竜湯煎液をさましたもの4
5mlを用いた。官能試験を実施した結果を表2に示
す。
The control (C) is a mixture of Shoseiryu-tosen 4
5 ml was used. Table 2 shows the results of the sensory test.

【0046】表2 C:対照(小青竜湯煎液45ml) I−5:本発明の実施例5の服用補助剤 I−6:本発明の実施例6の服用補助剤 I−7:本発明の実施例7の服用補助剤 I−8:本発明の実施例8の服用補助剤 Table 2 C: Control (45 ml of Shoseiryu-tosen) I-5: Auxiliary agent for taking Example 5 of the present invention I-6: Auxiliary agent for taking of Example 6 of the present invention I-7: The present invention Taking Aid of Example 7 of I-8: Taking Aid of Example 8 of the Present Invention

【0047】オレンジ・ミルク味の服用補助剤について
も対照と比較して明らかに優れていた。またレシチンお
よびゲル化剤を変えても同様の結果が得られることが判
明した。
The orange milk flavored supplement was also clearly superior to the control. It was also found that similar results were obtained even when the lecithin and the gelling agent were changed.

【0048】官能試験2で煎液を得た直後に本発明の服
用補助剤を加え、冷蔵庫で冷却するとゼリー状となる。
このものについても官能試験を行った結果も表2と同様
であった。
Immediately after the decoction is obtained in the sensory test 2, the dosage aid of the present invention is added and the mixture is cooled in a refrigerator to form a jelly.
The results of the sensory test performed on this product were also the same as those in Table 2.

【0049】一般に漢方薬は特異な味や臭いをもってい
ることから、先の柴胡清肝湯エキス細粒および小青竜湯
煎液以外に、本発明の服用補助剤を用いて、柴胡桂枝
湯、柴胡桂枝乾姜湯、黄連解毒湯、麻黄湯、人参湯、麻
杏甘石湯、香蘇散、苓甘姜味辛夏仁湯、参蘇飲、荊芥連
翹湯、かっ香正気散、三黄瀉心湯、葛根湯、葛根湯加辛
夷川きゅう、安中散、小柴胡湯、当帰四逆加呉茱萸生姜
湯、呉茱萸湯、九味檳ろう湯、大柴胡湯、辛夷清肺湯、
大建中湯等の処方について同様の官能試験を行った結
果、いずれの処方においても特異な味、臭いを感じさせ
ることなく服用可能となった。
In general, Chinese herbal medicines have a unique taste and odor. In addition to the above-mentioned fine granules of Saiko Seikoto extract and Shoseiryu-to decoction, the adjuvant of the present invention can be used to produce Saiko Keishi-to, Saiko Keishi-in Jang-to, Oren-dokuto, Maoto-to, Ginseng-to, Makyo-kan-ishi-to, Koso-san, Ryo-kan-kyo-ko-jin-jin-in-to, Sanso-drink, Jingaku-ren-to-ryo-to, Kuka-Senki-san, San-o-shashin-to, Kakkon Hot water, kakkonto kashiikawa kyu, annakasan, shosaikoto, tokishikagakushu goshuyu ginger hot water, goshuyuto, kumi beniroto, daisaikoto, shinyiseito,
A similar sensory test was conducted for the prescriptions such as Daikenchuto, and as a result, it was possible to take any of the prescriptions without giving any particular taste or smell.

【0050】官能試験3 ドライシロップ製剤ではあるが、顆粒状であるために乳
幼児には服用困難であるため、水に溶かして服用させよ
うとすると特有のえぐみを伴う苦味が出てくるマクロラ
イド系抗生物質のクラリスロマイシン(大日本製薬
(株)、クラリシッド小児用ドライシロップ)0.5gに
実施例9〜12の顆粒4gを加え、80℃の熱水40m
lを加え良く撹拌した後、冷蔵庫で冷却しゼリー化し
た。対照(C)はクラリスロマイシンドライシロップ0.
5gに水40mlを加え良く攪拌し溶解させ服用する。
Sensory test 3 Although it is a dry syrup preparation, it is difficult for infants to take it because it is granulated, so if it is dissolved in water, it will give a bitter taste accompanied by a peculiar taste when it is taken. The antibiotic clarithromycin (Dainippon Pharmaceutical)
4 g of the granules of Examples 9 to 12 were added to 0.5 g of a dry syrup for children, and 40 m of hot water at 80 ° C was added.
After adding 1 and stirring well, the mixture was cooled in a refrigerator to form a jelly. Control (C) was clarithromycin dry syrup at 0.
Add 40 ml of water to 5 g, stir well to dissolve and take.

【0051】苦味低減方法に記載の服用補助剤(II)は、
官能試験1で調製したチョコレート味付剤5.22gお
よびκ−カラギーナン0.38gに、クラリスロマイシ
ンドライシロップ0.5gを加え、80℃の熱水25m
lに攪拌溶解した後、冷却しゼリー化する。
The dosage aid (II) described in the method for reducing bitterness includes:
To 5.22 g of the chocolate flavoring agent prepared in the sensory test 1 and 0.38 g of κ-carrageenan, 0.5 g of clarithromycin dry syrup was added, and 25 m of hot water at 80 ° C.
After stirring and dissolving in 1 l, the mixture is cooled and jellied.

【0052】文献報告例記載の服用補助剤(III)は、ク
ラリスロマイシンドライシロップ0.5gに単シロップ
8mlと熱水3mlを加え、加温しながら溶解する。製
菓用ゼライス0.55gを2mlの水に膨潤させ湯煎で
溶解した。上記にミルクココア粉末(森永製菓(株))2.
5gと湯3mlを加えて加温しながら溶解し、冷却して
ゼリー化する。比較官能試験を実施した結果を表3に示
す。
The dosage aid (III) described in the literature report example is prepared by adding 8 ml of simple syrup and 3 ml of hot water to 0.5 g of clarithromycin dry syrup and dissolving while heating. 0.55 g of confectionery jelly was swelled in 2 ml of water and dissolved in hot water. Milk cocoa powder (Morinaga Inc.) 2.
5 g and 3 ml of hot water are added, dissolved while heating, and cooled to jelly. Table 3 shows the results of the comparative sensory test.

【0053】表3 C:対照(クラリスロマイシンドライシロップ0.5
g) I−9:本発明の実施例9の服用補助剤 I−10:本発明の実施例10の服用補助剤 I−11:本発明の実施例11の服用補助剤 I−12:本発明の実施例12の服用補助剤 II:苦味低減方法に記載の服用補助剤 III:文献報告例記載の服用補助剤
Table 3 C: Control (clarithromycin dry syrup 0.5
g) I-9: Taking aid of Example 9 of the present invention I-10: Taking aid of Example 10 of the present invention I-11: Taking aid of Example 11 of the present invention I-12: Present invention Taking aid of Example 12 II: Taking aid described in Bitter Taste Reduction Method III: Taking aid described in Reference Report Examples

【0054】本発明の服用補助剤は対照および文献報告
例の服用補助剤と比較して明らかに優れた結果を示し
た。
The dosage aid of the present invention showed clearly superior results as compared with the dosage aids of the control and literature reported examples.

【0055】本発明の服用補助剤を用いて、マクロライ
ド系抗生物質以外にセフェム系抗生物質である塩酸セフ
カペンピボキシル(塩野義製薬(株)、フロモックス小児
用細粒)や、セフジトレンピボキシル(明治製菓(株)、
メイアクト小児用顆粒)についても同様に官能試験を行
った結果、いずれの抗生物質でも苦味を感じさせること
なく服用可能となった。
Using the dosage aid of the present invention, cefcapene pivoxil hydrochloride (Shinogi Pharmaceutical Co., Ltd., Flomox pediatric fine granules) and cefditoren other than macrolide antibiotics, which are cephem antibiotics, Pivoxil (Meiji Seika Co., Ltd.,
The same sensory test was conducted for Meyact pediatric granules), and as a result, any antibiotic could be taken without causing bitterness.

【0056】官能試験4 配合剤であるレシチンは苦味マスキング剤ではあるが、
脳の健康維持のための補助食品としても利用されてお
り、1回に数グラム服用されている。レシチン自体は若
干油っぽい味がするのみで、臭いはほとんど無いのであ
るが、数グラムも一度に服用しようとすると口中に違和
感を感じ服用しづらい物である。そこでレシチン3gに
実施例13〜16の顆粒4gを加え、80℃の熱水50
mlを加え良く撹拌した後、冷蔵庫で冷却しゼリー化し
た。対照(C)は市販の顆粒状レシチン3gをそのまま口
に含み服用する。官能試験を実施した結果を表4に示
す。
Sensory Test 4 Although lecithin as a compounding agent is a bitterness masking agent,
It is also used as a supplement for maintaining brain health, and is taken several grams at a time. Lecithin itself has a little oily taste and almost no smell, but if you try to take a few grams at a time, it feels uncomfortable in your mouth and is difficult to take. Therefore, 4 g of the granules of Examples 13 to 16 were added to 3 g of lecithin, and hot water 50 ° C. at 80 ° C. was added.
Then, the mixture was stirred well, cooled in a refrigerator and gelled. Control (C) takes 3 g of commercially available granular lecithin as it is in the mouth. Table 4 shows the results of the sensory test.

【0057】表4 C:対照(レシチン3g) I−13:本発明の実施例13の服用補助剤 I−14:本発明の実施例14の服用補助剤 I−15:本発明の実施例15の服用補助剤 I−16:本発明の実施例16の服用補助剤 Table 4 C: Control (3 g of lecithin) I-13: Taking aid of Example 13 of the present invention I-14: Taking aid of Example 14 of the present invention I-15: Example 15 of the present invention Taking Aid I-16: Taking Aid of Example 16 of the Invention

【0058】本発明の服用補助剤4gにはレシチンが
1.6g含まれており、最終的にレシチン4.6gを服用
することになるにもかかわらず、対照と比較すると本発
明の服用補助剤を用いるときレシチンを容易に服用でき
ることがわかった。また、実施例1〜12の服用補助剤
についても同様の官能試験を行った結果、レシチンをき
わめて容易に服用することができた。
4 g of the dosage aid of the present invention contains 1.6 g of lecithin, and although the final dosage of lecithin is 4.6 g, the dosage of the dosage aid of the present invention is higher than that of the control. It was found that lecithin could be easily taken when using. In addition, the same sensory test was performed on the dosage aids of Examples 1 to 12, and as a result, lecithin could be taken very easily.

【0059】表1〜表4の官能試験結果にも示されるよ
うに、非常に服用し難かった医薬品等に本発明の服用補
助剤を加え、温湯あるいは熱湯に溶かした後、冷却しゾ
ル状あるいはゼリー状とすることにより、全員が違和感
を感ずることなく服用可能となった。本発明は苦味低減
方法や文献報告例のようにゼリー状として口中への広が
りを抑制する効果のみでは抑えきれなかった味、臭い、
ならびに苦味低減剤のレシチンのみでは抑えられなかっ
た苦味以外の他の酸味、えぐみを、ゲル化剤にミルク香
味料を含む基本ベース、またはさらにこれにカカオ末と
チョコレート香料もしくはオレンジという香料を組合わ
せることにより、相乗的な抑制効果が現れたものと考え
られる。
As shown in the results of the sensory tests in Tables 1 to 4, the auxiliaries of the present invention were added to medicines, etc., which were extremely difficult to take, dissolved in warm water or hot water, and then cooled to form a sol. By making it jelly-like, everyone could take it without feeling uncomfortable. The present invention is a bitterness reducing method and the effect of suppressing the spread in the mouth as a jelly like a literature report example, the taste, odor, which could not be completely suppressed,
In addition, bitterness other than the bitterness that was not suppressed only by lecithin, bitterness other than the bitterness, a basic base containing a milk flavoring agent as a gelling agent, or further combined with a cocoa powder and a chocolate flavoring or orange flavoring It is considered that a synergistic suppression effect appears by combining them.

【0060】[0060]

【発明の効果】本発明は、乳幼児などに服用困難であっ
た医薬品、介護が必要な老人などに服用させにくかった
医薬品、あるいは健康維持のためには必要と理解してい
ても服用困難であった健康食品等を違和感なく服用でき
るようにするという効果を持つ。
According to the present invention, it is difficult to take medicines that are difficult to take for infants, etc., medicines that are difficult for elderly people who need nursing care, etc., or that it is necessary to maintain health. It has the effect of allowing healthy health foods and the like to be taken without discomfort.

【0061】また本発明は、温湯で溶かすことによりゾ
ル状、熱湯に溶かして冷蔵庫で冷却することによりゼリ
ー状になるというように、服用者の状態、ニーズに合っ
た服用法の選択枝を増やす効果も持つ。
In addition, the present invention increases the number of options for taking a dosage method that suits the condition of the user and the needs, such as dissolving in hot water to form a sol, or dissolving in hot water and cooling in a refrigerator to form a jelly. It also has an effect.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 35/78 A61K 35/78 C 47/22 47/22 47/36 47/36 47/44 47/44 47/46 47/46 Fターム(参考) 4B018 LE04 MD09 MD25 MD37 MD46 MD57 MD94 ME14 4B035 LC01 LE04 LG06 LG13 LG16 LG23 LG25 LG27 LG33 LK02 4C076 AA31 AA99 BB01 DD43 DD59 DD63 EE30 EE41 EE58 FF52 4C086 AA01 CC10 CC12 EA13 MA52 NA09 ZB35 4C088 AB04 AB11 AB12 AB32 AB33 AB60 AB65 BA37 MA52 NA09──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 35/78 A61K 35/78 C 47/22 47/22 47/36 47/36 47/44 47/44 47/46 47/46 F-term (reference) 4B018 LE04 MD09 MD25 MD37 MD46 MD57 MD94 ME14 4B035 LC01 LE04 LG06 LG13 LG16 LG23 LG25 LG27 LG33 LK02 4C076 AA31 AA99 BB01 DD43 DD59 DD63 EE30 EE41 EE58 FF52 4C086 AA01BCC CC 4C088 AB04 AB11 AB12 AB32 AB33 AB60 AB65 BA37 MA52 NA09

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 レシチンとミルク香味料の組合せ、ゲル
化剤、およびアスコルビン酸ならびにクエン酸三ナトリ
ウムを含み、アスコルビン酸ならびにクエン酸三ナトリ
ウムが、アスコルビン酸:クエン酸三ナトリウム=3〜
5:1の割合で含まれることを特徴とする服用補助剤。
1. A combination of a lecithin and milk flavoring agent, a gelling agent, and ascorbic acid and trisodium citrate, wherein the ascorbic acid and trisodium citrate are ascorbic acid: trisodium citrate = 3 to
A dosage aid characterized in that it is contained in a ratio of 5: 1.
【請求項2】 上記割合がアスコルビン酸:クエン酸三
ナトリウム=4:1である、請求項1記載の服用補助
剤。
2. The dosage aid according to claim 1, wherein the ratio is ascorbic acid: trisodium citrate = 4: 1.
【請求項3】 ゾル状またはゼリー状で服用される、請
求項1または2記載の服用補助剤。
3. The dosage aid according to claim 1, which is taken in a sol form or a jelly form.
【請求項4】 ゲル化剤がκ−カラギーナンおよびロー
カストビーンガムである、請求項1〜3のいずれか1項
記載の服用補助剤。
4. The dosage aid according to claim 1, wherein the gelling agent is κ-carrageenan and locust bean gum.
【請求項5】 ゲル化剤がκ−カラギーナン、ローカス
トビーンガムおよびキサンタンガムである、請求項1〜
3のいずれか1項記載の服用補助剤。
5. The gelling agent according to claim 1, wherein the gelling agent is κ-carrageenan, locust bean gum and xanthan gum.
4. The dose aid according to any one of the above items 3.
【請求項6】 苦味薬のための、カカオ末およびチョコ
レート香味料をさらに含む、請求項1〜5のいずれか1
項記載の服用補助剤。
6. The method according to claim 1, further comprising a cocoa powder and a chocolate flavor for a bitter medicine.
The dosage aid described in the item.
【請求項7】 酸味薬のための、オレンジ香味料をさら
に含む、請求項1〜5のいずれか1項記載の服用補助
剤。
7. The dosage aid according to any one of claims 1 to 5, further comprising an orange flavor for sour agents.
【請求項8】 レシチンおよび請求項1〜7に記載の服
用補助剤からなるレシチン製剤。
8. A lecithin preparation comprising lecithin and the dosage aid according to claims 1 to 7.
JP2000039421A 2000-02-17 2000-02-17 Taking assisting agent Pending JP2001226293A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000039421A JP2001226293A (en) 2000-02-17 2000-02-17 Taking assisting agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000039421A JP2001226293A (en) 2000-02-17 2000-02-17 Taking assisting agent

Publications (1)

Publication Number Publication Date
JP2001226293A true JP2001226293A (en) 2001-08-21

Family

ID=18562986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000039421A Pending JP2001226293A (en) 2000-02-17 2000-02-17 Taking assisting agent

Country Status (1)

Country Link
JP (1) JP2001226293A (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002128705A (en) * 2000-10-23 2002-05-09 Taisho Pharmaceut Co Ltd Medicinal basic preparation having unpleasant taste
JP2004059503A (en) * 2002-07-29 2004-02-26 Teikoku Kanpo Seiyaku Kk Chinese medicine-based jellylike pharmaceutical composition
WO2005072536A1 (en) * 2004-01-16 2005-08-11 The Iams Company Liquid supplement compositions comprising one or more medicaments
WO2006001344A1 (en) * 2004-06-24 2006-01-05 Sanwa Kagaku Kenkyusho Co., Ltd. Isosorbide-containing jelly preparation
JP2008043217A (en) * 2006-08-11 2008-02-28 Kobayashi Pharmaceut Co Ltd Food composition
WO2008084533A1 (en) * 2007-01-10 2008-07-17 Kowa Co., Ltd. Therapeutic agent for meniere’s disease
DE202008006492U1 (en) 2007-02-23 2008-08-21 Basf Se Use of water-dispersible carotenoid nanoparticles as taste modulators, flavor modulators containing water-dispersible carotenoid nanoparticles
DE202008006491U1 (en) 2007-02-23 2008-08-21 Basf Se Use of azo compounds for taste modulation of compositions containing at least one high intensity sweetener (HIS)
WO2008102019A2 (en) 2007-02-23 2008-08-28 Basf Se Use of water-dispersible carotinoid nanoparticles as taste modulators, taste modulators containing water-dispersible carotinoid nanoparticles, and method for taste modulation
DE202008006163U1 (en) 2008-03-05 2008-10-02 Basf Se Use of a salt preparation for flavor modulation of compositions containing at least one High Intensity Sweetener (HIS)
DE202008006164U1 (en) 2008-03-05 2008-10-02 Basf Se Use of a polyoxyethylene sorbitan fatty acid ester for taste modulation of compositions containing at least one High Intensity Sweetener (HIS)
WO2013081120A1 (en) * 2011-11-30 2013-06-06 学校法人日本大学 Lecithin-organogel-forming agent
US8809398B2 (en) 2007-01-16 2014-08-19 Basf Se Liquid formulations containing a carotinoid
WO2015156246A1 (en) * 2014-04-10 2015-10-15 サントリーホールディングス株式会社 Method for masking bitterness of composition containing collagen peptide
JPWO2013176243A1 (en) * 2012-05-25 2016-01-14 学校法人日本大学 Lecithin organogel former
US9375387B2 (en) 2008-10-07 2016-06-28 Basf Se Ready-to-use, stable emulsion
US11185093B2 (en) 2007-11-29 2021-11-30 Christian Köpsel Pulverulent carotenoid preparation for colouring drinks
US11388914B2 (en) 2015-04-28 2022-07-19 Mars, Incorporated Process of preparing a wet pet food, wet pet food produced by the process and uses thereof

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125719A (en) * 1975-04-24 1976-11-02 Wakamoto Pharmaceut Co Ltd A method for preparing a liquid medicine for internal use
JPS6049751A (en) * 1983-08-29 1985-03-19 Ajinomoto Co Inc Food composition
JPS62265234A (en) * 1986-05-14 1987-11-18 Showa Yakuhin Kako Kk Preparation composition for suppressing bitterness
JPH04346937A (en) * 1991-05-24 1992-12-02 Kibun Foods Inc Reduction of bitterness
JPH0543474A (en) * 1991-06-05 1993-02-23 Tsumura & Co Herb preparation composition for ready administration
JPH0668A (en) * 1992-06-18 1994-01-11 Sanwa Kagaku Kenkyusho Co Ltd Composition containing concentrated fats and oils of marine animal and food containing the same composition
JPH06500594A (en) * 1991-01-07 1994-01-20 カビ ファルマシア アクチェボラーグ Composition of natural antioxidants for stabilization of polyunsaturated oils
JPH06284866A (en) * 1993-02-05 1994-10-11 Kao Corp Taste improver
JPH09187233A (en) * 1996-01-12 1997-07-22 Ota Seiyaku Kk Jelly composition
JPH10175849A (en) * 1996-12-13 1998-06-30 Miyoshi Oil & Fat Co Ltd Active oxygen inhibiting composition
JPH11139992A (en) * 1997-11-10 1999-05-25 Taisho Pharmaceut Co Ltd Liquid composition for drinking
JPH11228450A (en) * 1997-03-28 1999-08-24 Eisai Co Ltd Oral medicine in which bitter taste and the like are masked
JPH11292769A (en) * 1998-04-10 1999-10-26 Toyo Seiyaku Kasei Kk Hyperpotassemia-improving agent composition
JPH11322624A (en) * 1998-05-06 1999-11-24 Ina Food Ind Co Ltd Chinese medicine/crude medicine preparation to be prepared in time of use

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125719A (en) * 1975-04-24 1976-11-02 Wakamoto Pharmaceut Co Ltd A method for preparing a liquid medicine for internal use
JPS6049751A (en) * 1983-08-29 1985-03-19 Ajinomoto Co Inc Food composition
JPS62265234A (en) * 1986-05-14 1987-11-18 Showa Yakuhin Kako Kk Preparation composition for suppressing bitterness
JPH06500594A (en) * 1991-01-07 1994-01-20 カビ ファルマシア アクチェボラーグ Composition of natural antioxidants for stabilization of polyunsaturated oils
JPH04346937A (en) * 1991-05-24 1992-12-02 Kibun Foods Inc Reduction of bitterness
JPH0543474A (en) * 1991-06-05 1993-02-23 Tsumura & Co Herb preparation composition for ready administration
JPH0668A (en) * 1992-06-18 1994-01-11 Sanwa Kagaku Kenkyusho Co Ltd Composition containing concentrated fats and oils of marine animal and food containing the same composition
JPH06284866A (en) * 1993-02-05 1994-10-11 Kao Corp Taste improver
JPH09187233A (en) * 1996-01-12 1997-07-22 Ota Seiyaku Kk Jelly composition
JPH10175849A (en) * 1996-12-13 1998-06-30 Miyoshi Oil & Fat Co Ltd Active oxygen inhibiting composition
JPH11228450A (en) * 1997-03-28 1999-08-24 Eisai Co Ltd Oral medicine in which bitter taste and the like are masked
JPH11139992A (en) * 1997-11-10 1999-05-25 Taisho Pharmaceut Co Ltd Liquid composition for drinking
JPH11292769A (en) * 1998-04-10 1999-10-26 Toyo Seiyaku Kasei Kk Hyperpotassemia-improving agent composition
JPH11322624A (en) * 1998-05-06 1999-11-24 Ina Food Ind Co Ltd Chinese medicine/crude medicine preparation to be prepared in time of use

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
斉藤百枝美他, 医薬ジャーナル, vol. 35, no. 11, JPN4006003236, 1999, pages 171 - 177, ISSN: 0000711888 *
斉藤百枝美他, 医薬ジャーナル, vol. 35, no. 11, JPNX006023728, 1999, pages 171 - 177, ISSN: 0000743652 *
桂木能久, 月刊フードケミカル, vol. 2, JPN4006003237, 1998, pages 53 - 57, ISSN: 0000711889 *
桂木能久, 月刊フードケミカル, vol. 2, JPNX006023729, 1998, pages 53 - 57, ISSN: 0000743653 *
桂木能久他, 日本味と匂学会誌, vol. 3, no. 3, JPN4006003238, 1996, pages 183 - 186, ISSN: 0000711890 *
桂木能久他, 日本味と匂学会誌, vol. 3, no. 3, JPNX006023730, 1996, pages 183 - 186, ISSN: 0000743654 *

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002128705A (en) * 2000-10-23 2002-05-09 Taisho Pharmaceut Co Ltd Medicinal basic preparation having unpleasant taste
JP4706096B2 (en) * 2000-10-23 2011-06-22 大正製薬株式会社 Formulation of basic drug with unpleasant taste
EP1541130A4 (en) * 2002-07-29 2009-01-07 Teikoku Kanpo Seiyaku Co Ltd Chinese herbal medical composition in the form of jelly
JP2004059503A (en) * 2002-07-29 2004-02-26 Teikoku Kanpo Seiyaku Kk Chinese medicine-based jellylike pharmaceutical composition
US9364428B2 (en) 2002-07-29 2016-06-14 Teikoku Seiyaku Co., Ltd. Herb medicine composition in the form of jelly
WO2005072536A1 (en) * 2004-01-16 2005-08-11 The Iams Company Liquid supplement compositions comprising one or more medicaments
WO2006001344A1 (en) * 2004-06-24 2006-01-05 Sanwa Kagaku Kenkyusho Co., Ltd. Isosorbide-containing jelly preparation
JP2008043217A (en) * 2006-08-11 2008-02-28 Kobayashi Pharmaceut Co Ltd Food composition
WO2008084533A1 (en) * 2007-01-10 2008-07-17 Kowa Co., Ltd. Therapeutic agent for meniere’s disease
US8809398B2 (en) 2007-01-16 2014-08-19 Basf Se Liquid formulations containing a carotinoid
DE202008006491U1 (en) 2007-02-23 2008-08-21 Basf Se Use of azo compounds for taste modulation of compositions containing at least one high intensity sweetener (HIS)
WO2008102019A2 (en) 2007-02-23 2008-08-28 Basf Se Use of water-dispersible carotinoid nanoparticles as taste modulators, taste modulators containing water-dispersible carotinoid nanoparticles, and method for taste modulation
DE202008006492U1 (en) 2007-02-23 2008-08-21 Basf Se Use of water-dispersible carotenoid nanoparticles as taste modulators, flavor modulators containing water-dispersible carotenoid nanoparticles
WO2008102018A2 (en) 2007-02-23 2008-08-28 Basf Se Method for modulating the taste of material compisitions containing at least one high intensity sweetener (his)
US11185093B2 (en) 2007-11-29 2021-11-30 Christian Köpsel Pulverulent carotenoid preparation for colouring drinks
WO2009109227A1 (en) 2008-03-05 2009-09-11 Basf Se Method for modulating the taste of material compositions containing at least one high intensity sweetener (his)
DE202008006164U1 (en) 2008-03-05 2008-10-02 Basf Se Use of a polyoxyethylene sorbitan fatty acid ester for taste modulation of compositions containing at least one High Intensity Sweetener (HIS)
WO2009109226A1 (en) 2008-03-05 2009-09-11 Basf Se Method for modulating the taste of material compositions containing at least one high intensity sweetener (his)
DE202008006163U1 (en) 2008-03-05 2008-10-02 Basf Se Use of a salt preparation for flavor modulation of compositions containing at least one High Intensity Sweetener (HIS)
US10004670B2 (en) 2008-10-07 2018-06-26 Basf Se Ready-to-use, stable emulsion
US9375387B2 (en) 2008-10-07 2016-06-28 Basf Se Ready-to-use, stable emulsion
WO2013081120A1 (en) * 2011-11-30 2013-06-06 学校法人日本大学 Lecithin-organogel-forming agent
JPWO2013081120A1 (en) * 2011-11-30 2015-04-27 学校法人日本大学 Lecithin organogel former
JPWO2013176243A1 (en) * 2012-05-25 2016-01-14 学校法人日本大学 Lecithin organogel former
WO2015156246A1 (en) * 2014-04-10 2015-10-15 サントリーホールディングス株式会社 Method for masking bitterness of composition containing collagen peptide
JPWO2015156246A1 (en) * 2014-04-10 2017-04-13 サントリーホールディングス株式会社 Bitter taste masking method for collagen peptide-containing composition
US20170028032A1 (en) * 2014-04-10 2017-02-02 Suntory Holdings Limited Method for masking bitterness of composition containing collagen peptide
AU2015244885B2 (en) * 2014-04-10 2020-04-30 Suntory Holdings Limited Method for masking bitterness of composition containing collagen peptide
CN106170213A (en) * 2014-04-10 2016-11-30 三得利控股株式会社 Bitterness concealing method containing collagen protein peptide combinations
US11388914B2 (en) 2015-04-28 2022-07-19 Mars, Incorporated Process of preparing a wet pet food, wet pet food produced by the process and uses thereof

Similar Documents

Publication Publication Date Title
US8287897B2 (en) Bitterness-masking particulate jelly beverage
JP2001226293A (en) Taking assisting agent
TWI405587B (en) Medicinal granulated jelly drink and preparation method thereof
JP4264105B2 (en) Isosorbide-containing jelly preparation
JP4884130B2 (en) Food composition
JPH04346937A (en) Reduction of bitterness
JPH04235136A (en) Method for reducing bitterness and composition for reducing bitterness
JPH07116049B2 (en) Easy-to-use Kampo formulation
JP2006052169A (en) Sol-like or gel-like administration assistant food
JP2003137797A (en) Mastic-containing emulsion
WO2016031292A1 (en) Additive for orally administered composition
JP4216447B2 (en) Swallowing aid
JP5691638B2 (en) Propolis composition and method for producing the same
JP6160098B2 (en) Method for producing unpleasant taste masking agent using complex of gallate type catechin and protein
JP5070669B2 (en) Oral gel preparation with improved antiseptic properties
TW201208715A (en) Dimemorfan oral liquid
JP2002104997A (en) Agent for easily taking food or medicine
JP6758619B2 (en) Composition
JP6854502B2 (en) Silk peptide-containing composition
WO2008080809A2 (en) Pharmaceutical composition containing psyllium and senna
JP2016199484A (en) Additive for oral composition
TW202130285A (en) Food composition
WO2020208630A1 (en) Sweetness blocker composition
JP2007215407A (en) Ceramide-containing food and ceramide-containing internal agent

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040914

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040921

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060131

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060606